Fresenius Medical Care (FME) Stock Overview
Provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for FME from our risk checks.
FME Community Fair Values
Create NarrativeSee what 27 others think this stock is worth. Follow their fair value or set your own to get alerts.
Fresenius Medical Care AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €46.56 |
| 52 Week High | €54.02 |
| 52 Week Low | €36.39 |
| Beta | 0.89 |
| 1 Month Change | 2.17% |
| 3 Month Change | 9.42% |
| 1 Year Change | 27.39% |
| 3 Year Change | 63.03% |
| 5 Year Change | -36.41% |
| Change since IPO | 184.19% |
Recent News & Updates
Capital Allocation Trends At Fresenius Medical Care (ETR:FME) Aren't Ideal
Oct 20
Is Fresenius Medical Care (ETR:FME) A Risky Investment?
Sep 23Recent updates
Capital Allocation Trends At Fresenius Medical Care (ETR:FME) Aren't Ideal
Oct 20Is Fresenius Medical Care (ETR:FME) A Risky Investment?
Sep 23A Piece Of The Puzzle Missing From Fresenius Medical Care AG's (ETR:FME) Share Price
Aug 23Fresenius Medical Care AG Just Missed EPS By 81%: Here's What Analysts Think Will Happen Next
Aug 08When Should You Buy Fresenius Medical Care AG (ETR:FME)?
Jul 07Fresenius Medical Care (ETR:FME) Could Be At Risk Of Shrinking As A Company
Jun 21Fresenius Medical Care AG's (ETR:FME) 29% Jump Shows Its Popularity With Investors
May 21We Discuss Why Fresenius Medical Care AG's (ETR:FME) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
May 16Earnings Update: Fresenius Medical Care AG (ETR:FME) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
May 09Fresenius Medical Care's (ETR:FME) Upcoming Dividend Will Be Larger Than Last Year's
Apr 09Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 14Why Fresenius Medical Care's (ETR:FME) Earnings Are Better Than They Seem
Mar 05Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.44
Feb 28Is Now The Time To Look At Buying Fresenius Medical Care AG (ETR:FME)?
Feb 21What You Can Learn From Fresenius Medical Care AG's (ETR:FME) P/E
Feb 06Here's What's Concerning About Fresenius Medical Care's (ETR:FME) Returns On Capital
Dec 22What Is Fresenius Medical Care AG's (ETR:FME) Share Price Doing?
Nov 21
Strategic Innovations And Cost Efficiency Propel Growth In Global Healthcare Markets
Strategic focus on operational performance and cost savings initiatives is anticipated to enhance operating margins and improve earnings.Shareholder Returns
| FME | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -0.3% | 0.8% | -1.6% |
| 1Y | 27.4% | 39.2% | 13.0% |
Return vs Industry: FME underperformed the German Healthcare industry which returned 37.7% over the past year.
Return vs Market: FME exceeded the German Market which returned 12.6% over the past year.
Price Volatility
| FME volatility | |
|---|---|
| FME Average Weekly Movement | 3.1% |
| Healthcare Industry Average Movement | 6.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 12.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: FME has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: FME's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 112,445 | Helen Giza | www.freseniusmedicalcare.com |
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments.
Fresenius Medical Care AG Fundamentals Summary
| FME fundamental statistics | |
|---|---|
| Market cap | €13.48b |
| Earnings (TTM) | €656.42m |
| Revenue (TTM) | €19.52b |
Is FME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FME income statement (TTM) | |
|---|---|
| Revenue | €19.52b |
| Cost of Revenue | €14.70b |
| Gross Profit | €4.81b |
| Other Expenses | €4.16b |
| Earnings | €656.42m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Nov 04, 2025
| Earnings per share (EPS) | 2.27 |
| Gross Margin | 24.67% |
| Net Profit Margin | 3.36% |
| Debt/Equity Ratio | 51.4% |
How did FME perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/03 03:38 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Fresenius Medical Care AG is covered by 41 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Olav Zilian | Baader Helvea Equity Research |
| Benjamin Mayo | Baird |
| Robert Bate | Barclays |